Editas Medicine Q3 EPS $(0.15) Beats $(0.18) Estimate, Sales $10.365M Beat $4.460M Estimate
Benzinga Newsdesk 29 minutes ago
NewsEarningsEarnings Beats
Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 46.43 percent increase over losses of $(0.28) per share from
Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 46.43 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $10.365 million which beat the analyst consensus estimate of $4.460 million by 132.40 percent. This is a 37.41 percent increase over sales of $7.543 million the same period last year.